If advocates of drug price controls had their way years ago, remdesivir likely wouldn’t be available today to treat coronavirus patients, write John F. Cogan and George P. Shultz

If advocates of drug price controls had their way years ago, remdesivir likely wouldn’t be available today to treat coronavirus patients, write John F. Cogan and George P. Shultz https://t.co/Yaxgq0JO0H

— WSJ Editorial Page (@WSJopinion) May 2, 2020